The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis.

Bibliographic Details
Title: The GDF15 3′ UTR Polymorphism rs1054564 Is Associated with Diabetes and Subclinical Atherosclerosis.
Authors: Guardiola, Montse1,2,3,4 (AUTHOR), Girona, Josefa1,2,3,4 (AUTHOR), Barroso, Emma4,5,6,7 (AUTHOR), García-Altares, María4,8 (AUTHOR), Ibarretxe, Daiana1,2,3,4 (AUTHOR), Plana, Núria1,2,3,4 (AUTHOR), Ribalta, Josep1,2,3,4 (AUTHOR), Correig, Xavier4,8 (AUTHOR), Vázquez-Carrera, Manuel4,5,6,7 (AUTHOR), Masana, Lluís1,2,3,4 (AUTHOR), Rodríguez-Calvo, Ricardo1,2,3,4 (AUTHOR) ricardo.rodriguez@ciberdem.org
Source: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11985. 10p.
Subject Terms: *GROWTH differentiation factors, *ATHEROSCLEROTIC plaque, *GENETIC variation, *SINGLE nucleotide polymorphisms, *METABOLIC disorders
Abstract: Growth differentiation factor 15 (GDF15) is a stress-response cytokine related to a wide variety of metabolic diseases. However, the impact of GDF15-specific genetic variants on the abovementioned conditions is poorly known. The aim of this study was to assess the impact of selected GDF15 single-nucleotide polymorphisms (SNPs) on metabolic disturbances and subclinical atherosclerosis. A cross-sectional study involving 153 participants of a metabolic patient-based cohort was performed. Three selected SNPs (rs888663, rs1054564 and rs1059369) in a locus on chromosome 19 including the GDF15 gene were genotyped by Polymerase Chain Reaction (PCR), and its relationship with the serum GDF15 levels, health status and clinical variables were analyzed. Of the three SNPs analyzed, only rs1054564 showed different distributions between the healthy volunteers and patients suffering lipid alterations and associated disorders. Accordingly, just the rs1054564 variant carriers showed a significant increase in GDF15 serum levels compared to the wild-type carriers. The group of variant carriers showed a higher frequency of individuals with diabetes, compared to the wild-type carrier group, without showing differences in other metabolic conditions. Additionally, the frequency of individuals with atherosclerotic carotid plaque was higher in the rs1054564 variant carriers than in the wild-type carriers. Logistic regression models identified that the presence of the rs1054564 variant carriers increase the likelihood for both diabetes and carotid plaque independently of confounding factors. Overall, the findings of this study identify the rs1054564 variant as a potential indicator for the likelihood of diabetes and subclinical atherosclerosis. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
Full text is not displayed to guests.
More Details
ISSN:16616596
DOI:10.3390/ijms252211985
Published in:International Journal of Molecular Sciences
Language:English